These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 37700438

  • 1. YTHDF2 promotes gallbladder cancer progression and gemcitabine resistance via m6A-dependent DAPK3 degradation.
    Bai X, Chen J, Zhang W, Zhou S, Dong L, Huang J, He X.
    Cancer Sci; 2023 Nov; 114(11):4299-4313. PubMed ID: 37700438
    [Abstract] [Full Text] [Related]

  • 2. VIRMA contributes to non-small cell lung cancer progression via N6-methyladenosine-dependent DAPK3 post-transcriptional modification.
    Xu Y, Chen Y, Yao Y, Xie H, Lu G, Du C, Cheng J, Zhou J.
    Cancer Lett; 2021 Dec 01; 522():142-154. PubMed ID: 34520821
    [Abstract] [Full Text] [Related]

  • 3. ELF3 promotes gemcitabine resistance through PKMYT1/CDK1 signaling pathway in gallbladder cancer.
    Yang L, Wang H, Guo M, He M, Zhang W, Zhan M, Liu Y.
    Cell Oncol (Dordr); 2023 Aug 01; 46(4):1085-1095. PubMed ID: 36988891
    [Abstract] [Full Text] [Related]

  • 4. Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma.
    Zhang C, Sun Q, Zhang X, Qin N, Pu Z, Gu Y, Yan C, Zhu M, Dai J, Wang C, Li N, Jin G, Ma H, Hu Z, Zhang E, Tan F, Shen H.
    Cancer Commun (Lond); 2022 Jul 01; 42(7):609-626. PubMed ID: 35730068
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
    Chen M, Wei L, Law CT, Tsang FH, Shen J, Cheng CL, Tsang LH, Ho DW, Chiu DK, Lee JM, Wong CC, Ng IO, Wong CM.
    Hepatology; 2018 Jun 01; 67(6):2254-2270. PubMed ID: 29171881
    [Abstract] [Full Text] [Related]

  • 8. The m6A Reader YTHDF2 Promotes Bladder Cancer Progression by Suppressing RIG-I-Mediated Immune Response.
    Zhang L, Li Y, Zhou L, Zhou H, Ye L, Ou T, Hong H, Zheng S, Zhou Z, Wu K, Yan Z, Thiery JP, Cui J, Wu S.
    Cancer Res; 2023 Jun 02; 83(11):1834-1850. PubMed ID: 36939388
    [Abstract] [Full Text] [Related]

  • 9. RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A-YTHDF2-dependent manner.
    Shen D, Lin J, Xie Y, Zhuang Z, Xu G, Peng S, Tang G, Bai L, Zhu M, Zhang Y, Huang Z, Wang P, Liu X, Huang M, Luo Y, Wang X, Yu H.
    Clin Transl Med; 2023 May 02; 13(5):e1279. PubMed ID: 37203239
    [Abstract] [Full Text] [Related]

  • 10. NONO promotes gallbladder cancer cell proliferation by enhancing oncogenic RNA splicing of DLG1 through interaction with IGF2BP3/RBM14.
    Yang ZY, Zhao C, Liu SL, Pan LJ, Zhu YD, Zhao JW, Wang HK, Ye YY, Qiang J, Shi LQ, Mei JW, Xie Y, Gong W, Shu YJ, Dong P, Xiang SS.
    Cancer Lett; 2024 Apr 10; 587():216703. PubMed ID: 38341127
    [Abstract] [Full Text] [Related]

  • 11. YTHDF2 protein stabilization by the deubiquitinase OTUB1 promotes prostate cancer cell proliferation via PRSS8 mRNA degradation.
    Zhao X, Lv S, Li N, Zou Q, Sun L, Song T.
    J Biol Chem; 2024 Apr 10; 300(4):107152. PubMed ID: 38462165
    [Abstract] [Full Text] [Related]

  • 12. N6-methyladenosine reader YTHDF2 promotes multiple myeloma cell proliferation through EGR1/p21cip1/waf1/CDK2-Cyclin E1 axis-mediated cell cycle transition.
    Liu R, Miao J, Jia Y, Kong G, Hong F, Li F, Zhai M, Zhang R, Liu J, Xu X, Wang T, Liu H, Hu J, Yang Y, He A.
    Oncogene; 2023 May 10; 42(20):1607-1619. PubMed ID: 37012388
    [Abstract] [Full Text] [Related]

  • 13. YTHDF1 promotes gallbladder cancer progression via post-transcriptional regulation of the m6A/UHRF1 axis.
    Chen J, Bai X, Zhang W, Yan Z, Liu Y, Zhou S, Wu X, He X, Yang A.
    J Cell Mol Med; 2024 May 10; 28(9):e18328. PubMed ID: 38683130
    [Abstract] [Full Text] [Related]

  • 14. Long non-coding RNA SSTR5-AS1 facilitates gemcitabine resistance via stabilizing NONO in gallbladder carcinoma.
    Xue Z, Yang B, Xu Q, Zhu X, Qin G.
    Biochem Biophys Res Commun; 2020 Feb 19; 522(4):952-959. PubMed ID: 31810606
    [Abstract] [Full Text] [Related]

  • 15. METTL3-mediated N6-methyladenosine modification of DUSP5 mRNA promotes gallbladder-cancer progression.
    Chen HD, Li F, Chen S, Zhong ZH, Gao PF, Gao WZ.
    Cancer Gene Ther; 2022 Jul 19; 29(7):1012-1020. PubMed ID: 34799724
    [Abstract] [Full Text] [Related]

  • 16. YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.
    Zhang C, Huang S, Zhuang H, Ruan S, Zhou Z, Huang K, Ji F, Ma Z, Hou B, He X.
    Oncogene; 2020 Jun 19; 39(23):4507-4518. PubMed ID: 32366907
    [Abstract] [Full Text] [Related]

  • 17. IGF2BP3 promotes progression of gallbladder carcinoma by stabilizing KLK5 mRNA in N6-methyladenosine-dependent binding.
    Zhang J, Yang K, Bu J, Yan J, Hu X, Liu K, Gao S, Tang S, Gao L, Chen W.
    Front Oncol; 2022 Jun 19; 12():1035871. PubMed ID: 36313631
    [Abstract] [Full Text] [Related]

  • 18. METTL3-regulated m6A modification impairs the decidualization of endometrial stromal cells by regulating YTHDF2-mediated degradation of FOXO1 mRNA in endometriosis-related infertility.
    Li X, Jin J, Long X, Weng R, Xiong W, Liang J, Liu J, Sun J, Cai X, Zhang L, Liu Y.
    Reprod Biol Endocrinol; 2023 Oct 27; 21(1):99. PubMed ID: 37891533
    [Abstract] [Full Text] [Related]

  • 19. YTHDF2 promotes multiple myeloma cell proliferation via STAT5A/MAP2K2/p-ERK axis.
    Hua Z, Wei R, Guo M, Lin Z, Yu X, Li X, Gu C, Yang Y.
    Oncogene; 2022 Mar 27; 41(10):1482-1491. PubMed ID: 35075244
    [Abstract] [Full Text] [Related]

  • 20. SUMOylation of the m6A reader YTHDF2 by PIAS1 promotes viral RNA decay to restrict EBV replication.
    Sugiokto FG, Saiada F, Zhang K, Li R.
    mBio; 2024 Feb 14; 15(2):e0316823. PubMed ID: 38236021
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.